|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 6, 167-172, Copyright © 1992 by European Association for Cardio-thoracic Surgery
ME Cowen, RB Howard, D Mulvin, CA Dawson and MR Johnston
In vivo isolated lung perfusion is a novel technique for targeting
anticancer therapy to the lung while avoiding systemic toxicity as normal
lung toxicity from the antitumour therapy becomes the limiting factor. This
study was performed to investigate the effects of hyperthermia on lung
function in an intact animal model in which both acute and subacute
toxicity could be monitored. Dogs underwent in vivo isolated lung
perfusion. A control group was perfused to a lung temperature of 37 degrees
C (group 1) and two other groups were treated in an identical manner except
that the perfusion temperature was 43 degrees-44.8 degrees C in group 2 and
greater than 45 degrees C in group 3. An assessment of lung injury was
performed pre-perfusion, immediately post-perfusion and 2 weeks
post-perfusion by measurement of extravascular lung water (Qev), serotonin
uptake and wet weight to dry weight ratio. Our findings showed that the
lung was tolerant to hyperthermia up to about 44 degrees C for 1 h.
Analysis of 4 animals who survived perfusion above 3/44.0 degrees C showed
a highly significant decrease in serotonin uptake between pre- and post-
perfusion values (82.4 +/- 1.2 vs 40.4 +/- 3.9, P less than 0.02); at 2
weeks serotonin uptake had returned to normal in all 3 dogs. Fulminating
pulmonary oedema developed at temperatures over 45 degrees C. Serotonin
uptake may be a sensitive predictor of thermal lung injury.
ARTICLES
Lung tolerance to hyperthermia by in vivo perfusion
Department of Surgery, University of Colorado Health Sciences Center, Denver.
This article has been cited by other articles:
![]() |
M. J. Grootenboers, J. Heeren, B. P Van putte, J. M. Hendriks, W. J Van boven, P. E. Van schil, and F. M. Schramel Isolated lung perfusion for pulmonary metastases, a review and work in progress Perfusion, September 1, 2006; 21(5): 267 - 276. [Abstract] [PDF] |
||||
![]() |
U. F.W. Franke, T. Wittwer, M. Lessel, K. Liebing, M. Albert, V. Becker, H. Schubert, and T. Wahlers Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I. Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 792 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nawata, N. Abecasis, H. M. Ross, A. Abolhoda, H. Cheng, K. S. Sachar, and M. E. Burt ISOLATED LUNG PERFUSION WITH MELPHALAN FOR THE TREATMENT OF METASTATIC PULMONARY SARCOMA J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1542 - 1548. [Abstract] [Full Text] |
||||
![]() |
M. R. Johnston, R. F. Minchen, and C. A. Dawson LUNG PERFUSION WITH CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE METASTATIC SARCOMA TO THE LUNG OR DIFFUSE BRONCHIOLOALVEOLAR CARCINOMA J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 368 - 373. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |